NCT05973344View on ClinicalTrials.gov

Understanding and Anticipating Therapeutic and ADverse Responses in Anti-cancer Immune Checkpoint Inhibition Towards a Better Therapeutic Management of Patients

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 9, 2024

Primary Completion Date

February 9, 2029

Study Completion Date

February 9, 2029

Conditions
Cancer
Trial Locations (1)

29200

RECRUITING

Brest University Hospital, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER